Cyp3a5 Genotyping

CYP3A5 Genotyping is a pharmacogenetic testing method that identifies genetic polymorphisms in the CYP3A5 gene to predict interindividual variability in the metabolism of calcineurin inhibitors, thereby guiding personalized immunosuppressive therapy.

359

Publications

21.6K

Citations

2.2K

Authors

658

Institutions

Publications per year

2017–2026

66

Authors

2.2K

  1. KE
    Kenneth E. Thummel

    University of Washington, United States

    11 publications · 3.2K citations

    11

    h-index

  2. VH
    Vincent Haufroid

    UCLouvain, Belgium

    9 publications · 851 citations

    9

    h-index

  3. LE
    Laure Elens

    UCLouvain, Belgium

    9 publications · 788 citations

    9

    h-index

  4. TH
    Tomonori Habuchi

    Akita University, Japan

    9 publications · 559 citations

    9

    h-index

  5. DK
    Dirk Kuypers

    KU Leuven, Belgium

    8 publications · 682 citations

    8

    h-index

1–5 of 2.2K

Venues

  1. Clinical Pharmacology & Therapeutics

    CPT · 26 publications · 3.5K citations

    23

    h-index

  2. Pharmacogenomics

    30 publications · 1.3K citations

    20

    h-index

  3. Therapeutic Drug Monitoring

    17 publications · 664 citations

    17

    h-index

  4. British Journal of Clinical Pharmacology

    BJCP · 12 publications · 568 citations

    12

    h-index

  5. Transplantation

    13 publications · 1K citations

    12

    h-index

1–5